UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The dopamine D3 receptor, a quarter century later

The European journal of neuroscience, 2017-01, Vol.45 (1), p.2-19

2017

Volltextzugriff (PDF)

A Functional Variant of the Dopamine D₃ Receptor Is Associated with Risk and Age-at-Onset of Essential Tremor

Proceedings of the National Academy of Sciences - PNAS, 2006-07, Vol.103 (28), p.10753-10758

2006

Volltextzugriff (PDF)

Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice

Nature communications, 2018-03, Vol.9 (1), p.1042-13, Article 1042

2018

Volltextzugriff (PDF)

Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist

European journal of pharmacology, 2021-01, Vol.890, p.173635-173635, Article 173635

2021

Volltextzugriff (PDF)

Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function

Nature medicine, 2003-06, Vol.9 (6), p.762-767

2003

Volltextzugriff (PDF)

Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents

The European journal of neuroscience, 2009-08, Vol.30 (3), p.397-414

2009

Volltextzugriff (PDF)

Effects of Paraxanthine and Caffeine on Sleep, Locomotor Activity, and Body Temperature in Orexin/Ataxin-3 Transgenic Narcoleptic Mice

Sleep (New York, N.Y.), 2010-07, Vol.33 (7), p.930-942

2010

Volltextzugriff (PDF)

Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels

Molecular pharmacology, 2008-10, Vol.74 (4), p.980-989

2008

Volltextzugriff (PDF)

Mass spectrometric detection and characterization of atypical membrane-bound zinc-sensitive phosphatases modulating GABAA receptors

PloS one, 2014-06, Vol.9 (6), p.e100612

2014

Volltextzugriff (PDF)

D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties

The Journal of biological chemistry, 2001-08, Vol.276 (32), p.30308-30314

2001

Volltextzugriff (PDF)

A Historical Perspective on the Dopamine D3 Receptor

Current topics in behavioral neurosciences, 2023, Vol.60, p.1-28

2023

Volltextzugriff (PDF)

The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade

Neuropharmacology, 2003-08, Vol.45 (2), p.174-181

2003

Volltextzugriff (PDF)

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

Proceedings of the National Academy of Sciences - PNAS, 1997-04, Vol.94 (7), p.3363-3367

1997

Volltextzugriff (PDF)

Development of Novel 1,2,3,4-Tetrahydroisoquinoline Derivatives and Closely Related Compounds as Potent and Selective Dopamine D₃ Receptor Ligands

Chembiochem : a European journal of chemical biology, 2004-04, Vol.5 (4), p.508-518

2004

Volltextzugriff (PDF)

Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors

European journal of pharmacology, 1999-02, Vol.366 (2-3), p.293-300

1999

Volltextzugriff (PDF)

Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats

The European journal of neuroscience, 2000-06, Vol.12 (6), p.2117-2123

2000

Volltextzugriff (PDF)

Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease

European journal of pharmacology, 2003-11, Vol.480 (1), p.89-95

2003

Volltextzugriff (PDF)

Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys

The Journal of pharmacology and experimental therapeutics, 2004-11, Vol.311 (2), p.770-777

2004

Volltextzugriff (PDF)

Cellular BRET assay suggests a conformational rearrangement of preformed TrkB/Shc complexes following BDNF-dependent activation

Cellular signalling, 2010-01, Vol.22 (1), p.158-165

2010

Volltextzugriff (PDF)

Molecular cloning and characterization of a novel dopamine receptor (D 3 ) as a target for neuroleptics

Nature (London), 1990-09, Vol.347 (6289), p.146-151

1990

Volltextzugriff (PDF)

Pharmacology profile of F17464, a dopamine D 3 receptor preferential antagonist

European journal of pharmacology, 2021-01, Vol.890, p.173635

2021

Volltextzugriff (PDF)

The dopamine D 3 receptor and drug dependence: Effects on reward or beyond?

Neuropharmacology, 2005-09, Vol.49 (4), p.525-541

2005

Volltextzugriff (PDF)

A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning

Neuroreport, 2005-02, Vol.16 (2), p.175-178

2005

Volltextzugriff (PDF)

Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings

Progress in brain research, 2014, Vol.211, p.255-275

2014

Volltextzugriff (PDF)

A functional variant of the dopamine D 3 receptor is associated with risk and age-at-onset of essential tremor

Proceedings of the National Academy of Sciences - PNAS, 2006-07, Vol.103 (28), p.10753-10758

2006

Volltextzugriff (PDF)

1 – 25 von 219

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(196)
Mit Volltextzugriff
(208)

Publikationsform

Sprache

Englisch
(210)
Französisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Animals
(76)
Life Sciences & Biomedicine
(71)
Humans
(55)
Biological And Medical Sciences
(50)
Receptors, Dopamine D3
(47)
Male
(44)
Rats
(42)
Neurosciences
(36)
Neurosciences & Neurology
(36)
Medical Sciences
(27)
Fundamental And Applied Biological Sciences. Psychology
(26)
Pharmacology & Pharmacy
(24)
Female
(23)
Mice
(21)
Dopamine
(20)
Dopamine Antagonists - Pharmacology
(19)
Schizophrenia
(19)
Neuropharmacology
(18)
Pharmacology. Drug Treatments
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The dopamine D3 receptor, a quarter century later

A Functional Variant of the Dopamine D₃ Receptor Is Associated with Risk and Age-at-Onset of Essential Tremor

Inhibition of neuronal FLT3 receptor tyrosine kinase alleviates peripheral neuropathic pain in mice

Pharmacology profile of F17464, a dopamine D3 receptor preferential antagonist

Attenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function

Striatal GPR88 expression is confined to the whole projection neuron population and is regulated by dopaminergic and glutamatergic afferents

Effects of Paraxanthine and Caffeine on Sleep, Locomotor Activity, and Body Temperature in Orexin/Ataxin-3 Transgenic Narcoleptic Mice

Paraxanthine, the Primary Metabolite of Caffeine, Provides Protection against Dopaminergic Cell Death via Stimulation of Ryanodine Receptor Channels

Mass spectrometric detection and characterization of atypical membrane-bound zinc-sensitive phosphatases modulating GABAA receptors

D2/D3 Dopamine Receptor Heterodimers Exhibit Unique Functional Properties

A Historical Perspective on the Dopamine D3 Receptor

The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade

Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa

Development of Novel 1,2,3,4-Tetrahydroisoquinoline Derivatives and Closely Related Compounds as Potent and Selective Dopamine D₃ Receptor Ligands

Functional potencies of new antiparkinsonian drugs at recombinant human dopamine D1, D2 and D3 receptors

Involvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats

Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease

Effect of the D3 dopamine receptor partial agonist BP897 [N-[4-(4-(2-methoxyphenyl)piperazinyl)butyl]-2-naphthamide] on L-3,4-dihydroxyphenylalanine-induced dyskinesias and parkinsonism in squirrel monkeys

Cellular BRET assay suggests a conformational rearrangement of preformed TrkB/Shc complexes following BDNF-dependent activation

Molecular cloning and characterization of a novel dopamine receptor (D 3 ) as a target for neuroleptics

Pharmacology profile of F17464, a dopamine D 3 receptor preferential antagonist

The dopamine D 3 receptor and drug dependence: Effects on reward or beyond?

A single cocaine exposure increases BDNF and D3 receptor expression: implications for drug-conditioning

Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings

A functional variant of the dopamine D 3 receptor is associated with risk and age-at-onset of essential tremor

Suchergebnisse filtern